Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3173 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3173 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1578 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0068 | 0.3173 | 1 |
Brugia malayi | TAR-binding protein | 0.0068 | 0.3173 | 0.3173 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0401 | 0.1265 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.1578 | 0.4975 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3173 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0401 | 0.1265 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0401 | 0.1265 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0401 | 0.1265 |
Loa Loa (eye worm) | TAR-binding protein | 0.0068 | 0.3173 | 0.3173 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0401 | 0.0401 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0068 | 0.3173 | 0.3173 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.0401 | 0.0401 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.2387 | 0.2387 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0401 | 0.1265 |
Loa Loa (eye worm) | RNA binding protein | 0.0068 | 0.3173 | 0.3173 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.2387 | 0.2387 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1578 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3173 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0017 | 0.0401 | 0.1265 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1578 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1468 | 0.1468 |
Brugia malayi | hypothetical protein | 0.0038 | 0.1578 | 0.1578 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0401 | 0.1265 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0068 | 0.3173 | 0.3173 |
Brugia malayi | RNA binding protein | 0.0068 | 0.3173 | 0.3173 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0017 | 0.0401 | 0.0401 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.1468 | 0.4626 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.1578 | 0.4975 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.2387 | 0.2387 |
Echinococcus granulosus | tar DNA binding protein | 0.0068 | 0.3173 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.1468 | 0.1468 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0401 | 0.1265 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.1578 | 0.4975 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.0401 | 0.0401 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0401 | 0.1265 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3173 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1578 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0017 | 0.0401 | 0.1265 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1578 | 0.4975 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.2387 | 0.2387 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.